Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Promastigote secretory gel from natural and unnatural sand fly vectors exacerbate Leishmania major and Leishmania tropica cutaneous leishmaniasis in mice

E. Giraud, M. Svobodová, I. Müller, P. Volf, ME. Rogers,

. 2019 ; 146 (14) : 1796-1802. [pub] 20190829

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
BB/H022406/1 Biotechnology and Biological Sciences Research Council - United Kingdom
GR078223MA Wellcome Trust - United Kingdom

Leishmania rely heavily on glycans to complete their digenetic life cycle in both mammalian and phlebotomine sand fly hosts. Leishmania promastigotes secrete a proteophosphoglycan-rich gel (Promastigote Secretory Gel, PSG) that is regurgitated during transmission and can exacerbate infection in the skin. Here we explored the role of PSG from natural Leishmania-sand fly vector combinations by obtaining PSG from Leishmania (L.) major-infected Phlebotomus (P.) papatasi and P. duboscqi and L. tropica-infected P. arabicus. We found that, in addition to the vector's saliva, the PSG from L. major and L. tropica potently exacerbated cutaneous infection in BALB/c mice, improved the probability of developing a patent cutaneous lesion, parasite growth and the evolution of the lesion. Of note, the presence of PSG in the inoculum more than halved the prepatent period of cutaneous L. tropica infection from an average of 32 weeks to 13 weeks. In addition, L. major and L. tropica PSG extracted from the permissive experimental vector, Lutzomyia (Lu.) longipalpis, also exacerbated infections in mice. These results reinforce and extend the hypothesis that PSG is an important and evolutionarily conserved component of Leishmania infection that can be used to facilitate experimental infection for drug and vaccine screening.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025457
003      
CZ-PrNML
005      
20201222153920.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1017/S0031182019001069 $2 doi
035    __
$a (PubMed)31452467
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Giraud, E $u Faculty of Infectious Tropical Diseases, Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK.
245    10
$a Promastigote secretory gel from natural and unnatural sand fly vectors exacerbate Leishmania major and Leishmania tropica cutaneous leishmaniasis in mice / $c E. Giraud, M. Svobodová, I. Müller, P. Volf, ME. Rogers,
520    9_
$a Leishmania rely heavily on glycans to complete their digenetic life cycle in both mammalian and phlebotomine sand fly hosts. Leishmania promastigotes secrete a proteophosphoglycan-rich gel (Promastigote Secretory Gel, PSG) that is regurgitated during transmission and can exacerbate infection in the skin. Here we explored the role of PSG from natural Leishmania-sand fly vector combinations by obtaining PSG from Leishmania (L.) major-infected Phlebotomus (P.) papatasi and P. duboscqi and L. tropica-infected P. arabicus. We found that, in addition to the vector's saliva, the PSG from L. major and L. tropica potently exacerbated cutaneous infection in BALB/c mice, improved the probability of developing a patent cutaneous lesion, parasite growth and the evolution of the lesion. Of note, the presence of PSG in the inoculum more than halved the prepatent period of cutaneous L. tropica infection from an average of 32 weeks to 13 weeks. In addition, L. major and L. tropica PSG extracted from the permissive experimental vector, Lutzomyia (Lu.) longipalpis, also exacerbated infections in mice. These results reinforce and extend the hypothesis that PSG is an important and evolutionarily conserved component of Leishmania infection that can be used to facilitate experimental infection for drug and vaccine screening.
650    _2
$a zvířata $7 D000818
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a Leishmania major $x chemie $7 D018320
650    _2
$a Leishmania tropica $x chemie $7 D007895
650    _2
$a leishmanióza kožní $x parazitologie $x patologie $7 D016773
650    _2
$a membránové proteiny $x aplikace a dávkování $x chemie $7 D008565
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a parazitární zátěž $7 D059208
650    _2
$a Phlebotomus $x parazitologie $7 D010691
650    _2
$a proteoglykany $x aplikace a dávkování $x chemie $7 D011509
650    _2
$a protozoální proteiny $x aplikace a dávkování $x chemie $7 D015800
650    _2
$a sliny $7 D012463
650    _2
$a kůže $x účinky léků $x parazitologie $x patologie $7 D012867
650    _2
$a syndrom vzplanutí nemoci $7 D000067251
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Svobodová, M $u Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Müller, I $u Faculty of Medicine, Division of Infectious Diseases, Department of Medicine, Section of Immunology at St. Mary's, Imperial College London, London, UK.
700    1_
$a Volf, P $u Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Rogers, M E $u Faculty of Infectious Tropical Diseases, Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.
773    0_
$w MED00010377 $t Parasitology $x 1469-8161 $g Roč. 146, č. 14 (2019), s. 1796-1802
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31452467 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222153916 $b ABA008
999    __
$a ok $b bmc $g 1599602 $s 1116143
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 146 $c 14 $d 1796-1802 $e 20190829 $i 1469-8161 $m Parasitology $n Parasitology $x MED00010377
GRA    __
$a BB/H022406/1 $p Biotechnology and Biological Sciences Research Council $2 United Kingdom
GRA    __
$a GR078223MA $p Wellcome Trust $2 United Kingdom
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...